Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - 2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

CAS No. 96680-77-2

2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one( —— )

Catalog No. M28385 CAS No. 96680-77-2

2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG 642 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one
  • Note
    Research use only, not for human use.
  • Brief Description
    2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.
  • Description
    2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Human Endogenous Metabolite|GPR109B|AhR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    96680-77-2
  • Formula Weight
    193.26
  • Molecular Formula
    C10H11NOS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1CC(=O)Nc2ccccc2S1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang XD, et al. A method for the determination of D-kynurenine in biological tissues. Anal Bioanal Chem. 2013 Dec;405(30):9747-54.
molnova catalog
related products
  • BAZ1A-IN-1

    BAZ1A-IN-1 is a potent BAZ1A inhibitor with the KD value of 0.52 μM for the BAZ1A bromodomain. BAZ1A-IN-1 shows good anti-survival activity against cancer cell lines with high BAZ1A expression, but weak or no activity against cancer cells with low BAZ1A expression.

  • SMARCA-BD ligand 1 f...

    SMARCA-BD ligand 1 for Protac is a compound that binds to SMARCA2, the BAF ATPase subunit, utilizing Protac technology to degrade SMARCA2.

  • GSK620

    GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.